Catalase Market By Source (Bovine liver, Micro-organisms, Others) , By Form (Liquid, Powder) By End-use (Food & beverage, Textile, Healthcare, Personal care, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

August 2024 | 250 pages | ID: CC8F4563E200EN
Allied Market Research

Abstracts

The catalase market was valued at $391.2 million in 2023, and is projected to reach $536.6 million by 2033, growing at a CAGR of 3.3% from 2024 to 2033.

Catalase is an is an ubiquitous tetrameric heme-containing enzyme found in nearly all living organisms exposed to oxygen. Its primary function is to decompose hydrogen peroxide, a harmful byproduct of many metabolic processes, into water and oxygen. It is particularly abundant in the liver and red blood cells, where detoxification processes are critical. It is crucial in protecting cells from oxidative damage by reactive oxygen species.

Increase in use of catalase in biotechnological applications, including enzyme-based assays and fermentation processes, is driving the growth catalase market. In addition, expansion of the food & beverage industry significantly contributes toward the market growth. This is attributed to the fact that catalase is used in food processing to remove hydrogen peroxide, enhancing food safety and extending shelf life. Furthermore, rise in awareness of the effects of oxidative stress on health has led to increased interest in antioxidant therapies, including catalase. Moreover, catalase is utilized in drug formulations and therapies, particularly in treating conditions associated with oxidative damage, thus spurring the market growth. However, high cost associated with with the extraction and purification of catalase acts as the key deterrent factor of the global market. In addition, availability of alternative enzymes or chemical processes that can achieve similar results may limit the demand for catalase in certain applications. On the contrary, ongoing research in enzyme applications, including catalase, in various fields like agriculture and medicine is expanding its market potential. Moreover, innovations in enzyme production and formulation technologies are enhancing the efficiency and efficacy of catalase. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.

The global catalase market is segmented on the basis of source, form, end use, and region. By source, the market is classified into bovine liver, micro-organisms, and others. Depending on form, it is categorized into liquid and powder. As per end use, it is fragmented into food & beverage, textile, healthcare, personal care, and others. Region wise, the catalase market is studied across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By source, the micro-organisms segment is expected to grow at a notable pace from 2024 to 2033.

Depending on form, the powder segment is anticipated to lead throughout the forecast period.

As per end use, the food & beverage segment is likely dominate the market during the forecast period.

Region wise, Asia-Pacific is projected to emerge as the most lucrative market for catalase in the coming future.

Competition Analysis

Competitive analysis and profiles of the major players in the global catalase market include MP Biomedicals LLC, Megazyme Inc, Sigma-Aldrich Co. LLC, BIO-CAT, Kolor Jet Chemical Pvt. Ltd., Biocatalysts Limited, Sekisui Diagnostics, LLC, Lumis Biotech Pvt. Ltd., and Novozymes. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• SWOT Analysis

Key Market Segments

By Source

• Bovine liver
• Micro-organisms
• Others

By Form

• Liquid
• Powder

By End-use

• Food beverage
• Textile
• Healthcare
• Personal care
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Germany
• Italy
• Spain
• UK
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• South Africa
• Saudi Arabia
• Rest of LAMEA
• Key Market Players
• MP Biomedicals LLC
• Megazyme Inc
• Sigma-Aldrich Co. LLC
• BIO-CAT
• Kolor Jet Chemical Pvt. Ltd.
• Biocatalysts Limited
• Sekisui Diagnostics, LLC
• Lumis Biotech Pvt. Ltd.
• Novozymes

Contents

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
  1.4.1. Primary Research
  1.4.2. Secondary Research
  1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
  3.3.1. Bargaining Power of Suppliers
  3.3.2. Threat of New Entrants
  3.3.3. Threat of Substitutes
  3.3.4. Competitive Rivalry
  3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
  3.4.1. Drivers
  3.4.2. Restraints
  3.4.3. Opportunities

CHAPTER 4: CATALASE MARKET, BY SOURCE

4.1. Market Overview
  4.1.1 Market Size and Forecast, By Source
4.2. Bovine Liver
  4.2.1. Key Market Trends, Growth Factors and Opportunities
  4.2.2. Market Size and Forecast, By Region
  4.2.3. Market Share Analysis, By Country
4.3. Micro-organisms
  4.3.1. Key Market Trends, Growth Factors and Opportunities
  4.3.2. Market Size and Forecast, By Region
  4.3.3. Market Share Analysis, By Country
4.4. Others
  4.4.1. Key Market Trends, Growth Factors and Opportunities
  4.4.2. Market Size and Forecast, By Region
  4.4.3. Market Share Analysis, By Country

CHAPTER 5: CATALASE MARKET, BY FORM

5.1. Market Overview
  5.1.1 Market Size and Forecast, By Form
5.2. Liquid
  5.2.1. Key Market Trends, Growth Factors and Opportunities
  5.2.2. Market Size and Forecast, By Region
  5.2.3. Market Share Analysis, By Country
5.3. Powder
  5.3.1. Key Market Trends, Growth Factors and Opportunities
  5.3.2. Market Size and Forecast, By Region
  5.3.3. Market Share Analysis, By Country

CHAPTER 6: CATALASE MARKET, BY END-USE

6.1. Market Overview
  6.1.1 Market Size and Forecast, By End-use
6.2. Food Beverage
  6.2.1. Key Market Trends, Growth Factors and Opportunities
  6.2.2. Market Size and Forecast, By Region
  6.2.3. Market Share Analysis, By Country
6.3. Textile
  6.3.1. Key Market Trends, Growth Factors and Opportunities
  6.3.2. Market Size and Forecast, By Region
  6.3.3. Market Share Analysis, By Country
6.4. Healthcare
  6.4.1. Key Market Trends, Growth Factors and Opportunities
  6.4.2. Market Size and Forecast, By Region
  6.4.3. Market Share Analysis, By Country
6.5. Personal Care
  6.5.1. Key Market Trends, Growth Factors and Opportunities
  6.5.2. Market Size and Forecast, By Region
  6.5.3. Market Share Analysis, By Country
6.6. Others
  6.6.1. Key Market Trends, Growth Factors and Opportunities
  6.6.2. Market Size and Forecast, By Region
  6.6.3. Market Share Analysis, By Country

CHAPTER 7: CATALASE MARKET, BY REGION

7.1. Market Overview
  7.1.1 Market Size and Forecast, By Region
7.2. North America
  7.2.1. Key Market Trends and Opportunities
  7.2.2. Market Size and Forecast, By Source
  7.2.3. Market Size and Forecast, By Form
  7.2.4. Market Size and Forecast, By End-use
  7.2.5. Market Size and Forecast, By Country
  7.2.6. U.S. Catalase Market
    7.2.6.1. Market Size and Forecast, By Source
    7.2.6.2. Market Size and Forecast, By Form
    7.2.6.3. Market Size and Forecast, By End-use
  7.2.7. Canada Catalase Market
    7.2.7.1. Market Size and Forecast, By Source
    7.2.7.2. Market Size and Forecast, By Form
    7.2.7.3. Market Size and Forecast, By End-use
  7.2.8. Mexico Catalase Market
    7.2.8.1. Market Size and Forecast, By Source
    7.2.8.2. Market Size and Forecast, By Form
    7.2.8.3. Market Size and Forecast, By End-use
7.3. Europe
  7.3.1. Key Market Trends and Opportunities
  7.3.2. Market Size and Forecast, By Source
  7.3.3. Market Size and Forecast, By Form
  7.3.4. Market Size and Forecast, By End-use
  7.3.5. Market Size and Forecast, By Country
  7.3.6. France Catalase Market
    7.3.6.1. Market Size and Forecast, By Source
    7.3.6.2. Market Size and Forecast, By Form
    7.3.6.3. Market Size and Forecast, By End-use
  7.3.7. Germany Catalase Market
    7.3.7.1. Market Size and Forecast, By Source
    7.3.7.2. Market Size and Forecast, By Form
    7.3.7.3. Market Size and Forecast, By End-use
  7.3.8. Italy Catalase Market
    7.3.8.1. Market Size and Forecast, By Source
    7.3.8.2. Market Size and Forecast, By Form
    7.3.8.3. Market Size and Forecast, By End-use
  7.3.9. Spain Catalase Market
    7.3.9.1. Market Size and Forecast, By Source
    7.3.9.2. Market Size and Forecast, By Form
    7.3.9.3. Market Size and Forecast, By End-use
  7.3.10. UK Catalase Market
    7.3.10.1. Market Size and Forecast, By Source
    7.3.10.2. Market Size and Forecast, By Form
    7.3.10.3. Market Size and Forecast, By End-use
  7.3.11. Rest Of Europe Catalase Market
    7.3.11.1. Market Size and Forecast, By Source
    7.3.11.2. Market Size and Forecast, By Form
    7.3.11.3. Market Size and Forecast, By End-use
7.4. Asia-Pacific
  7.4.1. Key Market Trends and Opportunities
  7.4.2. Market Size and Forecast, By Source
  7.4.3. Market Size and Forecast, By Form
  7.4.4. Market Size and Forecast, By End-use
  7.4.5. Market Size and Forecast, By Country
  7.4.6. China Catalase Market
    7.4.6.1. Market Size and Forecast, By Source
    7.4.6.2. Market Size and Forecast, By Form
    7.4.6.3. Market Size and Forecast, By End-use
  7.4.7. Japan Catalase Market
    7.4.7.1. Market Size and Forecast, By Source
    7.4.7.2. Market Size and Forecast, By Form
    7.4.7.3. Market Size and Forecast, By End-use
  7.4.8. India Catalase Market
    7.4.8.1. Market Size and Forecast, By Source
    7.4.8.2. Market Size and Forecast, By Form
    7.4.8.3. Market Size and Forecast, By End-use
  7.4.9. South Korea Catalase Market
    7.4.9.1. Market Size and Forecast, By Source
    7.4.9.2. Market Size and Forecast, By Form
    7.4.9.3. Market Size and Forecast, By End-use
  7.4.10. Australia Catalase Market
    7.4.10.1. Market Size and Forecast, By Source
    7.4.10.2. Market Size and Forecast, By Form
    7.4.10.3. Market Size and Forecast, By End-use
  7.4.11. Rest of Asia-Pacific Catalase Market
    7.4.11.1. Market Size and Forecast, By Source
    7.4.11.2. Market Size and Forecast, By Form
    7.4.11.3. Market Size and Forecast, By End-use
7.5. LAMEA
  7.5.1. Key Market Trends and Opportunities
  7.5.2. Market Size and Forecast, By Source
  7.5.3. Market Size and Forecast, By Form
  7.5.4. Market Size and Forecast, By End-use
  7.5.5. Market Size and Forecast, By Country
  7.5.6. Brazil Catalase Market
    7.5.6.1. Market Size and Forecast, By Source
    7.5.6.2. Market Size and Forecast, By Form
    7.5.6.3. Market Size and Forecast, By End-use
  7.5.7. South Africa Catalase Market
    7.5.7.1. Market Size and Forecast, By Source
    7.5.7.2. Market Size and Forecast, By Form
    7.5.7.3. Market Size and Forecast, By End-use
  7.5.8. Saudi Arabia Catalase Market
    7.5.8.1. Market Size and Forecast, By Source
    7.5.8.2. Market Size and Forecast, By Form
    7.5.8.3. Market Size and Forecast, By End-use
  7.5.9. Rest of LAMEA Catalase Market
    7.5.9.1. Market Size and Forecast, By Source
    7.5.9.2. Market Size and Forecast, By Form
    7.5.9.3. Market Size and Forecast, By End-use

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. MP Biomedicals LLC
  9.1.1. Company Overview
  9.1.2. Key Executives
  9.1.3. Company Snapshot
  9.1.4. Operating Business Segments
  9.1.5. Product Portfolio
  9.1.6. Business Performance
  9.1.7. Key Strategic Moves and Developments
9.2. Megazyme Inc
  9.2.1. Company Overview
  9.2.2. Key Executives
  9.2.3. Company Snapshot
  9.2.4. Operating Business Segments
  9.2.5. Product Portfolio
  9.2.6. Business Performance
  9.2.7. Key Strategic Moves and Developments
9.3. Sigma-Aldrich Co. LLC
  9.3.1. Company Overview
  9.3.2. Key Executives
  9.3.3. Company Snapshot
  9.3.4. Operating Business Segments
  9.3.5. Product Portfolio
  9.3.6. Business Performance
  9.3.7. Key Strategic Moves and Developments
9.4. BIO-CAT
  9.4.1. Company Overview
  9.4.2. Key Executives
  9.4.3. Company Snapshot
  9.4.4. Operating Business Segments
  9.4.5. Product Portfolio
  9.4.6. Business Performance
  9.4.7. Key Strategic Moves and Developments
9.5. Kolor Jet Chemical Pvt. Ltd.
  9.5.1. Company Overview
  9.5.2. Key Executives
  9.5.3. Company Snapshot
  9.5.4. Operating Business Segments
  9.5.5. Product Portfolio
  9.5.6. Business Performance
  9.5.7. Key Strategic Moves and Developments
9.6. Biocatalysts Limited
  9.6.1. Company Overview
  9.6.2. Key Executives
  9.6.3. Company Snapshot
  9.6.4. Operating Business Segments
  9.6.5. Product Portfolio
  9.6.6. Business Performance
  9.6.7. Key Strategic Moves and Developments
9.7. Sekisui Diagnostics, LLC
  9.7.1. Company Overview
  9.7.2. Key Executives
  9.7.3. Company Snapshot
  9.7.4. Operating Business Segments
  9.7.5. Product Portfolio
  9.7.6. Business Performance
  9.7.7. Key Strategic Moves and Developments
9.8. Lumis Biotech Pvt. Ltd.
  9.8.1. Company Overview
  9.8.2. Key Executives
  9.8.3. Company Snapshot
  9.8.4. Operating Business Segments
  9.8.5. Product Portfolio
  9.8.6. Business Performance
  9.8.7. Key Strategic Moves and Developments
9.9. Novozymes
  9.9.1. Company Overview
  9.9.2. Key Executives
  9.9.3. Company Snapshot
  9.9.4. Operating Business Segments
  9.9.5. Product Portfolio
  9.9.6. Business Performance
  9.9.7. Key Strategic Moves and Developments